Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Sembol: 2196.HK

HKSE

13.28

HKD

Bugünkü piyasa fiyatı

15.5749
F/K Oranı
7.2266
PEG Oranı
63.71B
MRK Kapağı
0.04%
DIV Verimi

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196-HK) Finansal Tablolar

Download

Yıllık Üç Aylık

Doğrusal Günlük

Grafikte için dinamiklerde varsayılan sayıları görebilirsiniz Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK). Şirketin geliri NaN M ortalamasını gösterir ki bu da NaN % gowth'dur. Tüm dönem için ortalama brüt kar NaN M olup NaN % dir. Ortalama brüt kar oranı NaN %dır. Şirketin geçen yılki performansı için net gelir artışı NaN % olup NaN % %'ne eşittir. tüm şirket geçmişi için ortalama.,

Yıllık Üç Aylık

10Y 20Y 30Y 40Y

Bilanço

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'nın mali yörüngesine baktığımızda, ortalama bir varlık büyümesi gözlemliyoruz. Bu oran, ilginç bir şekilde, şirketin hem en yüksek hem de en düşük seviyelerini yansıtarak olarak gerçekleşiyor. Çeyrekten çeyreğe karşılaştırıldığında, bu rakam olarak ayarlanmaktadır. Geçtiğimiz yıla bakıldığında toplam varlık değişiminin NaN olduğu görülür. Toplam özkaynak ile gösterilen hissedar değeri, raporlama para biriminde NaN olarak değerlenir. Bu açıdan yıldan yıla değişim NaN%'dir.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
balance-sheet.row.cash-and-short-term-investments	15582.1	17169.8	14549.2	11931.9	9989.9	9162.6	7468.2	6044.5	4062.4	3729.5	3111.6	5197.4	3125.9	3562.3	1308.5	1005.7	1079.6	991.3	752.9	688.1	1242.6	629.4	373.1	343.4	170	329.8	25.3	6.6	7.2
balance-sheet.row.short-term-investments	1888.5	928.5	4241.1	1970.1	456.7	616.1	219.3	48.5	33.8	33.8	44.2	224.8	231.3	218.8	11.7	0.1	5.8	2.1	0	5.2	0.2	285.3	0.9	0	0	0	0	0	0
balance-sheet.row.net-receivables	9967.9	10797.8	9517.7	7256.7	5873.4	5255.7	4522.5	2976.9	2518.7	3318.7	2256.4	1906.4	1797.3	1426.6	925.2	940.2	732.1	811	673.6	618.3	536.6	406.4	545.2	37.5	58.4	31.4	9.1	5.1	26.3
balance-sheet.row.inventory	7537.8	6882.4	5472.3	5162.8	3940.5	3287.4	2750.5	1670.7	1648.8	1604.6	1614.3	1273.4	1123.9	934.4	598	530.5	494.8	607.6	532	472.8	305.1	355.3	120.5	82.8	85	52.3	49.6	18	12.5
balance-sheet.row.other-current-assets	704.8	429.1	885.4	733.4	599.5	296	315.3	72.1	95.5	11.2	4.2	4.3	1.9	14.3	475.2	-59.2	210.6	6.5	3.3	0.5	19	16.1	6	207.7	117	96.6	132.7	77	57.4
balance-sheet.row.total-current-assets	33792.6	35279.2	30424.6	25084.8	20403.4	18001.7	15056.5	10764.3	8325.4	8664	6986.5	8381.5	6049.1	5937.7	3306.9	2417.3	2517.1	2416.4	1961.9	1779.7	2103.4	1407.2	1044.9	671.4	430.5	510.1	216.7	106.7	103.4
balance-sheet.row.property-plant-equipment-net	22239.4	16028.1	13283.9	13002.7	11085.1	9123.1	8315.9	6304.7	5764.9	5681.4	4907.5	3479.7	2627.3	1695.7	1258.8	1145.3	1139.1	1274.4	1240.6	1054	777.2	570.5	349.4	260.6	175.5	74.4	41.6	4.4	3.3
balance-sheet.row.goodwill	10852	10337.1	9400	8677.2	9014	8853.9	8464.3	3473.1	3303.4	3255	2976	1661.8	1585.1	296.4	51.1	51.1	51.1	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	17378.1	15925.3	13433.2	11498.6	10966.2	9192.1	8274.5	3650.6	3245.8	2911.9	2639.4	1782.3	1705.1	533.9	209	200.1	208.4	210.3	197.5	179	114.6	97.9	39.3	48	20.7	0.9	0.5	0	0
balance-sheet.row.goodwill-and-intangible-assets	28230.1	26262.4	22833.1	20175.9	19980.2	18046	16738.8	7123.7	6549.2	6166.9	5615.5	3444	3290.2	830.3	260.1	251.2	259.6	210.3	197.5	179	114.6	97.9	39.3	48	20.7	0.9	0.5	0	0
balance-sheet.row.long-term-investments	23123.8	24620.5	19679	21801.2	22564	23443.5	20904.5	18801.5	17200.5	14371.1	11560.7	9822.5	10011.5	7960.7	6652.3	3683.8	3465.1	2704.8	0	2108.4	1187.1	741.6	760.6	570.3	219.3	46.1	1.7	0	0
balance-sheet.row.tax-assets	624.5	442.6	265.6	244.9	196.1	173.1	144.5	129.6	102.5	101.2	88.1	31.5	16.7	18.4	11.4	12.9	11.8	5.6	0	20.1	36.5	322.4	15.5	-555.5	-211.5	10.6	10.3	0	0
balance-sheet.row.other-non-current-assets	5459.3	4531.2	6807.4	3376.5	1890.9	1763.9	810.8	644	259.3	351.6	316.9	347.9	295.9	377.5	37.6	28.5	42.3	22.3	2268.7	29.4	0	0	-2.4	576.3	223.8	4.9	16.3	0.2	0
balance-sheet.row.total-non-current-assets	79677	71884.7	62869.2	58601.2	55716.3	52549.6	46914.5	33003.5	29876.3	26672.3	22488.6	17125.6	16241.7	10882.5	8220.2	5121.6	4917.9	4217.5	3706.8	3390.8	2115.5	1732.4	1162.4	899.7	427.8	137	70.4	4.6	3.3
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	113469.6	107163.9	93293.8	83686	76119.6	70551.4	61971	43767.8	38201.7	35336.3	29475.2	25507.1	22290.8	16820.1	11527.1	7538.9	7435	6633.9	5668.7	5170.5	4218.8	3139.6	2207.3	1571.1	858.2	647.1	287.1	111.3	106.7
balance-sheet.row.account-payables	6159.6	6284	5063.7	3289	2397.3	2333.3	1781.9	1149.4	1048.6	905	1136.4	903.7	939.9	827.3	491.3	398	357.8	530.9	560.3	484	339.3	326.3	89.5	70.5	63.6	36.9	50.8	10.8	5.7
balance-sheet.row.short-term-debt	19555.1	17402.9	14547.6	14911.8	8920.5	10536.8	10478.2	5650.4	7334.2	3950.7	1424.2	875.3	2187.1	1830.4	1583	502.5	1556.4	1465.2	786.3	682	466.3	772.3	627.5	129.7	39.6	0	22.5	29.5	21
balance-sheet.row.tax-payables	537	929.8	727.5	564.7	759.6	478.9	480.1	478.2	503.8	342.9	288.9	162	111.7	247.4	48.9	49.5	73.7	42.1	27.8	38	62.6	61.3	9.5	16.2	8	12.1	10.4	0	-0.1
balance-sheet.row.long-term-debt-total	15554.5	12844.9	9697.4	9103	12987.1	12670.1	9814.9	5571	3571.5	3856.7	4199.7	4280.2	3915.1	2758.3	1284.5	1180.5	746.8	545.1	981.2	752.8	1026.9	45.8	25.2	25.2	13.8	30.1	0.5	0.4	14.3
Deferred Revenue Non Current	639.4	632.4	512.8	482.2	417.3	363.5	397.1	346.7	169.3	139.6	404.5	627.6	374.2	57.8	64.9	65.2	70.1	-449	-877.5	5.1	5.9	-38.8	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	125.2	9611.2	1528.6	54.6	249	4574.3	604.6	944.9	352.8	1337.1	309.5	729.9	221.9	110.6	67.6	541.3	44.1	18.8	40.1	33.6	34.1	32	27	16.4	9.2	37.3	0.6	22.7	34.1
balance-sheet.row.total-non-current-liabilities	23095.8	19756.9	15608.3	12829.4	19481.7	19035.4	15629.1	8408.9	6592.9	6696	6532.6	6309.3	5928.3	3723.4	2076.8	1337.8	900.5	642.4	1087.7	762.7	1035.3	53.9	25.2	27.9	13.8	42.1	0.5	0.4	14.8
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	2049.6	745	648.4	627.3	410.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	56853.3	53055	44918.2	37701.7	36915.4	36958.6	32229.6	18517.5	17532.1	16233.3	11810.7	10202.5	10920	7426.9	4575.1	3093	3118.6	2985.3	2793.7	2356.7	2201.9	1466.2	884.7	352.6	201.1	116.4	154.5	79.3	81.1
balance-sheet.row.preferred-stock	1300.1	1198.4	1265.8	933.6	468	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	2672.4	2672.2	2562.9	2562.9	2562.9	2563.1	2495.1	2414.5	2314.1	2311.6	2240.5	2240.5	1904.4	1904.4	1237.8	1237.8	1237.8	952.1	832	826.5	381.9	381.9	293.8	293.8	226.1	150.7	58.8	20	20
balance-sheet.row.retained-earnings	24542.5	23216.9	21039.6	17505	15125.7	12771.5	11111.6	8993.8	6937	5457	7112.7	5703	4483.5	3717.7	3258.2	1184.8	715.1	262.9	349.3	411.3	372.5	182.1	143.4	108.6	114.4	46.8	27.5	6.2	2.9
balance-sheet.row.accumulated-other-comprehensive-income-loss	-1300.1	-1198.4	-1265.8	-933.6	-468	-4436.3	-4000.5	-3047.9	-2592.5	-2164.5	-1671.5	-1213.5	-1061.4	-871.5	-654.1	-544.9	-478	0	-9	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	18469.9	18693.4	15589.5	16927.7	14199.5	17079.5	15720.6	13829.8	11523	11070.7	7650.6	6828.8	4445.4	3672.4	2634.7	2131.2	2397.4	1875.2	1218.6	1066.4	945.8	845.5	826.8	743.2	264.1	321.7	14.4	5.7	2.7
balance-sheet.row.total-stockholders-equity	45684.8	44582.5	39191.9	36995.5	31888.1	27977.7	25326.9	22190.2	18181.6	16674.8	15332.2	13558.8	9771.9	8423	6476.5	4008.9	3872.3	3090.2	2390.9	2304.1	1700.2	1409.5	1264	1145.5	604.5	519.1	100.7	32	25.6
balance-sheet.row.total-liabilities-and-stockholders-equity	113469.6	107163.9	93293.8	83686	76119.6	70551.4	61971	43767.8	38201.7	35336.3	29475.2	25507.1	22290.8	16820.1	11527.1	7538.9	7435	6633.9	5668.7	5170.5	4218.8	3139.6	2207.3	1571.1	858.2	647.1	287.1	111.3	106.7
balance-sheet.row.minority-interest	10931.5	9526.5	9183.6	8988.7	7316.1	5615	4414.6	3060.1	2488.1	2428.2	2332.3	1745.9	1599	970.2	475.5	437.1	444.1	558.3	484.2	509.7	316.7	263.9	58.7	73	52.6	11.6	32	0	0
balance-sheet.row.total-equity	56616.3	54108.9	48375.6	45984.3	39204.2	33592.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	25012.3	25549.1	23920.1	23771.3	23020.6	24059.6	21123.8	18850	17234.2	14404.9	11604.9	10047.3	10242.8	8179.4	6664	3683.9	3471	2706.9	2227.2	2113.6	1187.3	1026.9	760.6	570.3	219.3	46.1	1.7	0	0
balance-sheet.row.total-debt	35109.6	30247.7	24245	24014.8	21907.6	23206.9	20293.1	11221.3	10905.7	7807.4	5623.9	5155.5	6102.1	4588.7	2867.5	1683	2303.2	2010.3	1767.5	1434.8	1493.2	818.1	652.6	154.9	39.6	30.1	22.5	29.5	35.4
balance-sheet.row.net-debt	21416	14006.4	13936.9	14053	12374.4	14660.4	13044.2	5225.3	6877.1	4111.7	2556.5	183	3207.6	1245.2	1570.8	677.3	1229.4	1021.1	1014.6	752	250.8	474	280.4	-188.5	-130.4	-299.7	-2.8	22.9	28.2

Nakit Akış Tablosu

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'nın mali durumu son dönemde serbest nakit akışında kayda değer bir değişim göstererek NaN şeklinde bir değişim sergilemiştir. Şirket kısa süre önce NaN ihraç ederek sermayesini artırmış ve bir önceki yıla kıyasla NaN oranında bir farka işaret etmiştir. Şirketin yatırım faaliyetleri, raporlama para birimi cinsinden NaN tutarında net nakit kullanımıyla sonuçlanmıştır. Bu, bir önceki yıla göre NaN değişimidir. Aynı dönemde şirket, şirketin yatırım ve geri ödeme stratejilerini anlamada önemli olan NaN, NaN ve NaN 'i kaydetti. Şirketin finansman faaliyetleri NaN net nakit kullanımına yol açmış ve bir önceki yıla göre NaN farkı oluşmuştur. Ayrıca, şirket hissedarlarına temettü ödemeleri için NaN ayırmıştır. Aynı zamanda, NaN olarak adlandırılan ve bu dönemde nakit akışını önemli ölçüde etkileyen başka finansal manevralar da yapmıştır. Bu bileşenler birlikte ele alındığında, şirketin finansal durumu ve nakit akışı yönetimine yönelik stratejik yaklaşımı hakkında kapsamlı bir resim çizmektedir.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	2895.1	3947.5	4987.4	3940	3743.5	3019.9	3585.3	3221.3	2870.7	2369.8	2399.9	1839.3	1384.8	1000.3	2564.3	760.9	690.2	292.8	237.9	282.1	298.2	161.7	141.1	135.8	94.4	64.9
cash-flows.row.depreciation-and-amortization	2965.2	2335.9	1834.4	1666.2	1472.1	1320.1	938.6	732.9	649.3	558.4	415.5	286.2	209.9	152.7	134.7	132.5	136.5	132.1	116.7	91.1	56.1	37.6	28.6	28.1	20.1	9.3
cash-flows.row.deferred-income-tax	-2723.5	0	-4038.6	-2605.1	-2733	-1876.1	-2322.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	35.9	54.5	64.3	55.2	109.1	72.3	10.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-1081.2	-1387.9	259.7	-1401.4	-494.6	-535.1	-212.7	-288.1	-101.8	-555.3	-44.5	-28.2	-88.6	11	599.1	13.6	-133.7	-5.4	-107	789.2	23.2	-35	-45.2	0.8	-78	-10.8
cash-flows.row.account-receivables	1605.1	-2076.6	-1795	-1559.9	-863.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-333.9	-1430.1	-464.7	-1253.4	-505.2	-564.7	-491.1	-65.4	-88.3	-105	-149.6	-155.1	-99.8	-66.2	-70.1	-27.6	109.6	-42.7	-67	-27	56	-11.2	-37.5	12.4	-14.4	-4.9
cash-flows.row.account-payables	-1605.1	2076.6	1795	1559.9	863.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	-2352.4	42.2	724.5	-148	10.6	29.6	278.4	-222.7	-13.4	-450.3	105.1	126.9	11.2	77.2	669.2	41.2	-243.3	37.2	-40	816.2	-32.8	-23.8	-7.7	-11.6	-63.6	-5.9
cash-flows.row.other-non-cash-items	1322.7	-732.4	841.5	924.9	1125.3	949	580.8	-1556.1	-1797.2	-1172.7	-1759.4	-1431.8	-1189.5	-960.6	-3036.2	-673.9	-561.5	-234.6	-59.3	-957.3	-227.3	-61.8	-56.3	-26.3	1.7	3.2
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-5336.7	-5888.8	-4972.6	-4437.1	-3962.1	-3174.9	-2170.6	-1922	-1235.5	-1119.4	-1040.1	-1160.6	-796.8	-339.2	-348.1	-210.6	-209.7	-266.6	-222.6	-205	-264.1	-139.5	-141.5	-126.6	-78	-52.2
cash-flows.row.acquisitions-net	-923.7	-487.6	381.4	-140.3	-818.8	-622.6	-7822.6	-249.4	109.9	-1145.7	-2225.2	30.8	12.7	2.1	-2.6	22.8	9.3	18.2	279.9	11.6	25.5	4.9	10.8	17.6	1	0
cash-flows.row.purchases-of-investments	-943	-1501.3	-1424.6	-1070.1	-517.9	-2133.4	-2525.7	-1395.7	-2955.3	-1943.2	-364.1	-759.1	-1500.3	-1190.2	-770.2	-563.2	-543.7	-399.3	-349	-665.1	-134.9	-475.3	-317.8	-345.5	-253.5	-46
cash-flows.row.sales-maturities-of-investments	2809.3	4649.5	2168.3	2037.2	4916.2	1243.4	1550.6	1492.6	2127	1515.9	1540.7	1484.7	615.5	1348	755.5	822.8	632.3	329.6	76.6	45.4	535.7	254.8	243.5	30.2	43.4	0.4
cash-flows.row.other-investing-activites	574.8	-835.9	-9.5	-1095.8	210.6	-557.4	464.2	-372.6	83.9	214.2	285.2	-574.4	-97.6	-85	-32.5	-15.6	58	-17	-222.6	33.9	-0.2	204.6	-282	-19.3	48.2	-2
cash-flows.row.net-cash-used-for-investing-activites	-3819.3	-4064	-3857	-4706.2	-172	-5244.9	-10504.1	-2447.1	-1869.9	-2478.3	-1803.5	-978.6	-1766.5	-264.3	-397.8	56.1	-53.7	-335.1	-437.7	-779.2	162.1	-150.5	-487.1	-443.6	-238.9	-99.8
cash-flows.row.debt-repayment	-21146.2	-26280.1	-27391.9	-15707.8	-13942.1	-9995.1	-9085.3	-9956.1	-7239.7	-2559.5	-2417.6	-3795.9	-4042.2	-2081.7	-1071.9	-1410.2	-1753.9	-1221	-817.9	-727.4	-665.6	-1613.8	-716.1	-311.2	-62.8	-52.4
cash-flows.row.common-stock-issued	0	0	0	0	0	4851.4	3017.6	2728.5	116.1	1466.1	30.5	3151.1	0	637.8	18.9	16.1	17.2	0	0	9	951.5	8.4	6.7	437.6	0	372.4
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	14821.2	7694.5	8990.2	4017.4	2105.1	-17.8	0	3083.4	1703.6	1286	2100.3	0	0	873.7	-589.4	1691	1200.8	-48.5	0	-342.4
cash-flows.row.dividends-paid	-2455.2	-2374.4	-1914	-1834.6	-1864.4	-1775.5	-1433.5	-1193.5	-1109.3	-962.7	-804.5	-500.9	-437.3	-297.4	-268.6	-257.9	-237.6	-371.9	-200	-149.2	-94.9	-89.8	-78.2	-14.1	-13.4	-9.7
cash-flows.row.other-financing-activites	22265.1	33083	28474.6	19009.5	13870.5	10056.8	2588.7	2172.7	-206.6	-98.3	154.3	3231.9	5392.5	480.3	18.9	16.1	17.2	1963.6	1165.7	8.5	984.4	24.1	41	402.5	117.1	369.8
cash-flows.row.net-cash-used-provided-by-financing-activities	-1336.2	4428.5	-831.3	1467.1	-1936	3137.5	9908.6	1446	550.7	1863.1	-932.1	2068.4	913	1822.5	401	-349.9	143.1	370.7	147.8	14.6	586.1	19.9	454.2	466.3	41	337.7
cash-flows.row.effect-of-forex-changes-on-cash	73.6	128.3	-134.7	-300.2	-5.1	-18	-172.5	80.5	36.6	8.9	-31.4	-12	-6	-3.8	-0.7	-4.6	-4.8	-1.2	-0.4	0	-0.1	0	0	0.1	0	0
cash-flows.row.net-change-in-cash	-1667.7	4710.3	-874.2	-959.5	1109.4	824.7	1812.3	1189.4	338.4	593.9	-1755.3	1743.4	-542.9	1757.7	264.3	-65.4	216.1	219.3	-102	-559.5	898.3	-28.2	35.3	161.2	-159.7	304.5
cash-flows.row.cash-at-end-of-period	9502.4	11170.1	6450.7	7324.9	8284.4	7175	6350.3	4538	3348.6	3010.2	2416.3	4171.6	2428.2	2971.1	1213.4	949.1	1014.4	800.2	580.9	682.9	1242.4	344.1	372.3	343.4	170	329.8
cash-flows.row.cash-at-beginning-of-period	11170.1	6459.7	7324.9	8284.4	7175	6350.3	4538	3348.6	3010.2	2416.3	4171.6	2428.2	2971.1	1213.4	949.1	1014.4	798.4	580.9	682.9	1242.4	344.1	372.3	337	182.2	329.8	25.3
cash-flows.row.operating-cash-flow	3414.2	4217.6	3948.7	2579.8	3222.4	2950.1	2580.2	2110	1621	1200.2	1011.6	665.5	316.6	203.4	261.9	233	131.5	184.9	188.3	205.1	150.1	102.5	68.2	138.4	38.2	66.6
cash-flows.row.capital-expenditure	-5336.7	-5888.8	-4972.6	-4437.1	-3962.1	-3174.9	-2170.6	-1922	-1235.5	-1119.4	-1040.1	-1160.6	-796.8	-339.2	-348.1	-210.6	-209.7	-266.6	-222.6	-205	-264.1	-139.5	-141.5	-126.6	-78	-52.2
cash-flows.row.free-cash-flow	-1922.5	-1671.3	-1023.8	-1857.3	-739.6	-224.8	409.6	188.1	385.5	80.8	-28.4	-495.1	-480.2	-135.8	-86.2	22.4	-78.2	-81.7	-34.3	0.1	-113.9	-37	-73.4	11.8	-39.8	14.3

Gelir Tablosu Satırı

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'nın geliri bir önceki döneme göre NaN% oranında bir değişim gösterdi. Şirketin 2196.HK brüt kârı NaN olarak raporlanmıştır. Şirketin işletme giderleri NaN olup, geçen yıla göre NaN% değişim göstermiştir. Amortisman ve itfa giderleri NaN, yani NaN% son hesap dönemine göre değişimdir. İşletme giderleri NaN olarak raporlanmıştır ve yıldan yıla NaN% değişim göstermektedir. Satış ve pazarlama giderleri NaN, bir önceki yıla göre NaN% değişimdir. Son rakamlara göre FAVÖK NaN olup, yıldan yıla NaN% büyümeyi temsil etmektedir. Faaliyet geliri NaN olup, bir önceki yıla göre NaN% değişim göstermektedir. Net gelirdeki değişim NaN%'dir. Geçen yılın net geliri NaN idi.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
income-statement-row.row.total-revenue	41399.5	43951.5	39005.1	30307	28585.2	24918.3	18533.6	14628.8	12608.6	12025.5	9996.4	7340.8	6485.5	4555.4	3872.3	3773.2	3693.3	3102	2988.5	2425.4	2154.6	1031.7	727.8	579.5	442.5	340.4	190.3	92.7	64.7
income-statement-row.row.cost-of-revenue	21595.3	23169.7	20228.3	13431.2	11543.4	10365.3	7609	6718.4	6308	6718.6	5543.4	4126.8	3991.1	2984.6	2610.7	2711.9	2693.8	2282.2	2076	1651.9	1564	668.1	448.9	307.6	248.4	209.3	116.5	65.3	50.1
income-statement-row.row.gross-profit	19804.2	20781.9	18776.8	16875.8	17041.7	14553	10924.6	7910.5	6300.6	5307	4453	3214	2494.4	1570.9	1261.6	1061.4	999.5	819.8	912.5	773.6	590.5	363.6	279	271.9	194	131.1	73.9	27.3	14.5
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-17.9	2683.7	2276.4	1841.5	1666	44.1	-13.2	181.9	78.3	324.6	97.9	89.9	158.8	62.1	56	30.9	21.9	60.5	96.5	52.8	42.7	18.1	12.3	18.9	10.9	8	10	-0.3	0.5
income-statement-row.row.operating-expenses	18240.9	17145	16055.8	14045.6	14425.7	12185.7	8621	6168.5	4827.1	4114.5	3339.1	2620.4	2149	1394.5	1098.2	939.7	834.5	794.6	829.5	658.2	549.4	304.1	206.9	172.3	102.3	62.6	31.6	14.3	4.9
income-statement-row.row.cost-and-expenses	39836.2	40314.7	36284.1	27476.8	25969.1	22551	16230	12886.8	11135.2	10833.1	8882.5	6747.2	6140.2	4379.1	3708.8	3651.6	3528.3	3076.7	2905.5	2310.1	2113.4	972.2	655.7	480	350.7	271.9	148.1	79.6	55
income-statement-row.row.interest-income	363.6	282.6	233.7	199.6	186.6	145.7	79.2	80.9	56.2	69.8	63.8	29.7	51.6	19.6	14.5	17.9	12.5	13.8	17.5	13.7	8.7	2.9	13.7	8.1	0	0	0	0	0
income-statement-row.row.interest-expense	1324.8	963.8	822.5	881	1074.7	929.7	577.5	488.2	470	415	350.5	370.6	314	162.4	132.4	149.6	130.6	83.3	72	37	45.9	36.2	23.7	9.8	-6.1	-3.3	3.1	3	1.5
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-42.9	-3722.2	-259.9	-43.3	-1887.5	1212.3	1758.1	1829.5	1898.4	1525.6	1792.3	1529.5	1381.3	1025.6	3101.2	714	591.4	249.1	124.7	159.4	282.5	104.1	76.8	42.6	12.8	5.2	-3.1	-3.1	-1.4
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-17.9	2683.7	2276.4	1841.5	1666	44.1	-13.2	181.9	78.3	324.6	97.9	89.9	158.8	62.1	56	30.9	21.9	60.5	96.5	52.8	42.7	18.1	12.3	18.9	10.9	8	10	-0.3	0.5
income-statement-row.row.total-operating-expenses	-42.9	-3722.2	-259.9	-43.3	-1887.5	1212.3	1758.1	1829.5	1898.4	1525.6	1792.3	1529.5	1381.3	1025.6	3101.2	714	591.4	249.1	124.7	159.4	282.5	104.1	76.8	42.6	12.8	5.2	-3.1	-3.1	-1.4
income-statement-row.row.interest-expense	1324.8	963.8	822.5	881	1074.7	929.7	577.5	488.2	470	415	350.5	370.6	314	162.4	132.4	149.6	130.6	83.3	72	37	45.9	36.2	23.7	9.8	-6.1	-3.3	3.1	3	1.5
income-statement-row.row.depreciation-and-amortization	2965.2	2335.9	2986.4	2171.8	1472.1	1320.1	938.6	732.9	649.3	558.4	415.5	286.2	209.9	152.7	134.7	132.5	136.5	132.1	116.7	91.1	56.1	37.6	28.6	28.1	20.1	9.3	-7	3.3	1
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	3307.5	8296.6	6313.7	4721.1	6413.2	3535.5	4074.9	3399.4	3297.2	2394.3	2818.8	2036	1580.5	1140.5	3212	807.6	736.7	347.1	234.5	298.2	329.4	168.5	144.1	141.9	106.3	77.3	49.3	9.8	8.7
income-statement-row.row.income-before-tax	3264.6	4574.4	6053.8	4677.8	4525.8	3579.6	4061.7	3571.5	3371.8	2718.1	2906.3	2123	1726.7	1202	3264.7	835.7	756.4	341	269.3	312.9	347.8	175.1	152.7	151.4	110.9	79.5	49.3	9.7	8.7
income-statement-row.row.income-tax-expense	369.5	626.9	1066.4	737.9	782.2	559.7	476.5	350.2	501.2	348.2	506.3	283.8	341.8	201.6	700.4	74.7	66.2	48.2	31.4	30.8	49.6	13.6	11.6	15.7	16.5	12.9	9.1	3.4	2.7
income-statement-row.row.net-income	2386.3	3730.8	4728.7	3662.8	3321.6	2707.9	3124.5	2805.8	2460.1	2112.9	2027.1	1563.9	1165.6	863.7	2498.2	690.9	625.8	259.2	159	215.3	263.6	147.2	135.5	128.5	92.2	63.7	36	6.4	6